BOSTON — May 10, 2016 — On May 10, Greenberg Traurig, LLP’s Global Life Sciences & Medical Technology Group will host the 2016 Chinese Biotech Executives and Investors Delegation for a dinner reception and panel discussion in the firm’s Boston office. Comprised of top executives from some of China’s leading life sciences companies as well as institutional investors, the Chinese delegation seeks potential partnership and investment opportunities in the Boston/Cambridge area, one of the foremost biotech centers in the world.
From 5:30 – 7 p.m., Greenberg Traurig attorneys Dr. Fang Xie and Wayne H. Elowe, leaders of the firm’s Biotechnology and Pharmaceutical Industry Group, will lead the panel, “The Present and Future of Precision Medicine and Some Legal Considerations for Doing Business in the New Era.” Topics will include legal issues on U.S.-China cross-border transactions, IP protection, and recent changes in law in U.S. and China, as well as industrial perspectives on current trends in precision medicine. Boston Managing Shareholder Terence P. McCourt will also present on U.S. employment law considerations for China-based companies.
Xie, a life sciences patent attorney and of counsel in the firm’s Boston office, works with biotech and pharmaceutical companies and research institutions. Elowe, co-chair of the firm’s Atlanta Corporate & Securities Practice, has worked extensively on major deals involving Chinese companies. McCourt, who chairs the Boston Labor & Employment Practice, represents a broad range of organizations in all facets of management-side labor and employment law.